|Articles|November 11, 2022
physIQ Launches Intrepid Partner Program
The Intrepid Partner Program aims to accelerate the optimization of patient safety and health measurements in both clinical research and post market clinical care.
Advertisement
physIQ announced the launch of its Intrepid™ Partner Program, designed to enable the life sciences solutions ecosystem to deliver real time patient insights powered by medical grade biosensor data streams in both clinical and remote patient settings.
Read more about the program
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
BostonGene Expands AI-Driven Oncology Collaborations with New AstraZeneca Deal
2
Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial
3
ACT Brief: Rethinking Representation in Cancer Trials, Positive Phase IIb SLE Data, and a Major Obesity Drug Partnership
4
Securing Comparator Drugs in Competitive EU Markets: Challenges and Practical Solutions
5